 | • レポートコード：D0804-01658 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、102ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、バイオ医薬品バッファーの世界市場を広く調査・分析し、今後の市場展望をまとめております。バイオ医薬品バッファーの種類別市場規模（リン酸型、酢酸型、TRIS型、その他）、用途別市場規模（研究機関、製薬産業、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Avantor、Promega Corporation、Lonza、Alfa Aesar (Thermo Fisher)、GE Healthcare、Merck、XZL BIO-TECHNOLOGY、BD、Bio-Rad、Hamilton Company、SRL ・地域別グローバル市場分析 2015年-2020年 ・バイオ医薬品バッファーの北米市場（アメリカ、カナダ、メキシコ） ・バイオ医薬品バッファーのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・バイオ医薬品バッファーのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・バイオ医薬品バッファーの南米市場（ブラジル、アルゼンチン） ・バイオ医薬品バッファーの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：リン酸型、酢酸型、TRIS型、その他 ・用途別分析：研究機関、製薬産業、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Biopharma Buffer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Biopharma Buffer sales will be xx in 2020 from Biopharma Buffer million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Biopharma Buffer market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Biopharma Buffer industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Biopharma Buffer and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Biopharma Buffer market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Biopharma Buffer market has been segmented into
Phosphates Type
Acetates Type
TRIS Type
Others
By Application, Biopharma Buffer has been segmented into:
Research Institution
Pharmaceutical Industry
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biopharma Buffer market presented in the report. This section sheds light on the sales growth of different regional and country-level Biopharma Buffer markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biopharma Buffer market.
The report offers in-depth assessment of the growth and other aspects of the Biopharma Buffer market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Biopharma Buffer Market Share Analysis
Biopharma Buffer competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biopharma Buffer sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biopharma Buffer sales, revenue and market share for each player covered in this report.
The major players covered in Biopharma Buffer are:
Avantor
Promega Corporation
Lonza
Alfa Aesar (Thermo Fisher)
GE Healthcare
Merck
XZL BIO-TECHNOLOGY
BD
Bio-Rad
Hamilton Company
SRL
Among other players domestic and global, Biopharma Buffer market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biopharma Buffer product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biopharma Buffer, with price, sales, revenue and global market share of Biopharma Buffer in 2018 and 2019.
Chapter 3, the Biopharma Buffer competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biopharma Buffer breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Biopharma Buffer market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Biopharma Buffer sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Biopharma Buffer Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biopharma Buffer Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Phosphates Type
1.2.3 Acetates Type
1.2.4 TRIS Type
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Biopharma Buffer Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Research Institution
1.3.3 Pharmaceutical Industry
1.3.4 Others
1.4 Overview of Global Biopharma Buffer Market
1.4.1 Global Biopharma Buffer Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Biopharma Buffer Industry Impact
1.6.1 COVID-19 Potential Implications for the Biopharma Buffer
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Biopharma Buffer
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 Avantor
2.1.1 Avantor Details
2.1.2 Avantor Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Avantor SWOT Analysis
2.1.4 Avantor Product and Services
2.1.5 Avantor Biopharma Buffer Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Promega Corporation
2.2.1 Promega Corporation Details
2.2.2 Promega Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Promega Corporation SWOT Analysis
2.2.4 Promega Corporation Product and Services
2.2.5 Promega Corporation Biopharma Buffer Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Lonza
2.3.1 Lonza Details
2.3.2 Lonza Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Lonza SWOT Analysis
2.3.4 Lonza Product and Services
2.3.5 Lonza Biopharma Buffer Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Alfa Aesar (Thermo Fisher)
2.4.1 Alfa Aesar (Thermo Fisher) Details
2.4.2 Alfa Aesar (Thermo Fisher) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Alfa Aesar (Thermo Fisher) SWOT Analysis
2.4.4 Alfa Aesar (Thermo Fisher) Product and Services
2.4.5 Alfa Aesar (Thermo Fisher) Biopharma Buffer Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 GE Healthcare
2.5.1 GE Healthcare Details
2.5.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 GE Healthcare SWOT Analysis
2.5.4 GE Healthcare Product and Services
2.5.5 GE Healthcare Biopharma Buffer Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck SWOT Analysis
2.6.4 Merck Product and Services
2.6.5 Merck Biopharma Buffer Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 XZL BIO-TECHNOLOGY
2.7.1 XZL BIO-TECHNOLOGY Details
2.7.2 XZL BIO-TECHNOLOGY Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 XZL BIO-TECHNOLOGY SWOT Analysis
2.7.4 XZL BIO-TECHNOLOGY Product and Services
2.7.5 XZL BIO-TECHNOLOGY Biopharma Buffer Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 BD
2.8.1 BD Details
2.8.2 BD Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 BD SWOT Analysis
2.8.4 BD Product and Services
2.8.5 BD Biopharma Buffer Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bio-Rad
2.9.1 Bio-Rad Details
2.9.2 Bio-Rad Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bio-Rad SWOT Analysis
2.9.4 Bio-Rad Product and Services
2.9.5 Bio-Rad Biopharma Buffer Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Hamilton Company
2.10.1 Hamilton Company Details
2.10.2 Hamilton Company Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Hamilton Company SWOT Analysis
2.10.4 Hamilton Company Product and Services
2.10.5 Hamilton Company Biopharma Buffer Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 SRL
2.11.1 SRL Details
2.11.2 SRL Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 SRL SWOT Analysis
2.11.4 SRL Product and Services
2.11.5 SRL Biopharma Buffer Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Biopharma Buffer Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Biopharma Buffer Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Biopharma Buffer Manufacturer Market Share in 2019
3.3.2 Top 6 Biopharma Buffer Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Biopharma Buffer Sales, Revenue and Market Share by Regions
4.1.1 Global Biopharma Buffer Sales and Market Share by Regions (2015-2020)
4.1.2 Global Biopharma Buffer Revenue and Market Share by Regions (2015-2020)
4.2 North America Biopharma Buffer Sales and Growth Rate (2015-2020)
4.3 Europe Biopharma Buffer Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Biopharma Buffer Sales and Growth Rate (2015-2020)
4.5 South America Biopharma Buffer Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Biopharma Buffer Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Biopharma Buffer Sales, Revenue and Market Share by Country
5.1.1 North America Biopharma Buffer Sales and Market Share by Country (2015-2020)
5.1.2 North America Biopharma Buffer Revenue and Market Share by Country (2015-2020)
5.2 United States Biopharma Buffer Sales and Growth Rate (2015-2020)
5.3 Canada Biopharma Buffer Sales and Growth Rate (2015-2020)
5.4 Mexico Biopharma Buffer Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Biopharma Buffer Sales, Revenue and Market Share by Country
6.1.1 Europe Biopharma Buffer Sales and Market Share by Country (2015-2020)
6.1.2 Europe Biopharma Buffer Revenue and Market Share by Country (2015-2020)
6.2 Germany Biopharma Buffer Sales and Growth Rate (2015-2020)
6.3 UK Biopharma Buffer Sales and Growth Rate (2015-2020)
6.4 France Biopharma Buffer Sales and Growth Rate (2015-2020)
6.5 Russia Biopharma Buffer Sales and Growth Rate (2015-2020)
6.6 Italy Biopharma Buffer Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Biopharma Buffer Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Biopharma Buffer Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Biopharma Buffer Revenue and Market Share by Regions (2015-2020)
7.2 China Biopharma Buffer Sales and Growth Rate (2015-2020)
7.3 Japan Biopharma Buffer Sales and Growth Rate (2015-2020)
7.4 Korea Biopharma Buffer Sales and Growth Rate (2015-2020)
7.5 India Biopharma Buffer Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Biopharma Buffer Sales and Growth Rate (2015-2020)
7.7 Australia Biopharma Buffer Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Biopharma Buffer Sales, Revenue and Market Share by Country
8.1.1 South America Biopharma Buffer Sales and Market Share by Country (2015-2020)
8.1.2 South America Biopharma Buffer Revenue and Market Share by Country (2015-2020)
8.2 Brazil Biopharma Buffer Sales and Growth Rate (2015-2020)
8.3 Argentina Biopharma Buffer Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Biopharma Buffer Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Biopharma Buffer Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Biopharma Buffer Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Biopharma Buffer Sales and Growth Rate (2015-2020)
9.3 Turkey Biopharma Buffer Sales and Growth Rate (2015-2020)
9.4 Egypt Biopharma Buffer Sales and Growth Rate (2015-2020)
9.5 South Africa Biopharma Buffer Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Biopharma Buffer Sales and Market Share by Type (2015-2020)
10.2 Global Biopharma Buffer Revenue and Market Share by Type (2015-2020)
10.3 Global Biopharma Buffer Price by Type (2015-2020)
11 Global Biopharma Buffer Market Segment by Application
11.1 Global Biopharma Buffer Sales Market Share by Application (2015-2020)
11.2 Global Biopharma Buffer Revenue Market Share by Application (2015-2020)
11.3 Global Biopharma Buffer Price by Application (2015-2020)
12 Market Forecast
12.1 Global Biopharma Buffer Sales, Revenue and Growth Rate (2021-2025)
12.2 Biopharma Buffer Market Forecast by Regions (2021-2025)
12.2.1 North America Biopharma Buffer Market Forecast (2021-2025)
12.2.2 Europe Biopharma Buffer Market Forecast (2021-2025)
12.2.3 Asia-Pacific Biopharma Buffer Market Forecast (2021-2025)
12.2.4 South America Biopharma Buffer Market Forecast (2021-2025)
12.2.5 Middle East & Africa Biopharma Buffer Market Forecast (2021-2025)
12.3 Biopharma Buffer Market Forecast by Type (2021-2025)
12.3.1 Global Biopharma Buffer Sales Forecast by Type (2021-2025)
12.3.2 Global Biopharma Buffer Market Share Forecast by Type (2021-2025)
12.4 Biopharma Buffer Market Forecast by Application (2021-2025)
12.4.1 Global Biopharma Buffer Sales Forecast by Application (2021-2025)
12.4.2 Global Biopharma Buffer Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Biopharma Buffer Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biopharma Buffer by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biopharma Buffer Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Biopharma Buffer Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Avantor Basic Information, Manufacturing Base and Competitors
Table 9. Avantor Biopharma Buffer Major Business
Table 10. Avantor Biopharma Buffer Total Revenue (USD Million) (2018-2019)
Table 11. Avantor SWOT Analysis
Table 12. Avantor Biopharma Buffer Product and Services
Table 13. Avantor Biopharma Buffer Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Promega Corporation Basic Information, Manufacturing Base and Competitors
Table 15. Promega Corporation Biopharma Buffer Major Business
Table 16. Promega Corporation Biopharma Buffer Total Revenue (USD Million) (2018-2019)
Table 17. Promega Corporation SWOT Analysis
Table 18. Promega Corporation Biopharma Buffer Product and Services
Table 19. Promega Corporation Biopharma Buffer Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Lonza Basic Information, Manufacturing Base and Competitors
Table 21. Lonza Biopharma Buffer Major Business
Table 22. Lonza Biopharma Buffer Total Revenue (USD Million) (2018-2019)
Table 23. Lonza SWOT Analysis
Table 24. Lonza Biopharma Buffer Product and Services
Table 25. Lonza Biopharma Buffer Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Alfa Aesar (Thermo Fisher) Basic Information, Manufacturing Base and Competitors
Table 27. Alfa Aesar (Thermo Fisher) Biopharma Buffer Major Business
Table 28. Alfa Aesar (Thermo Fisher) Biopharma Buffer Total Revenue (USD Million) (2018-2019)
Table 29. Alfa Aesar (Thermo Fisher) SWOT Analysis
Table 30. Alfa Aesar (Thermo Fisher) Biopharma Buffer Product and Services
Table 31. Alfa Aesar (Thermo Fisher) Biopharma Buffer Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 33. GE Healthcare Biopharma Buffer Major Business
Table 34. GE Healthcare Biopharma Buffer Total Revenue (USD Million) (2018-2019)
Table 35. GE Healthcare SWOT Analysis
Table 36. GE Healthcare Biopharma Buffer Product and Services
Table 37. GE Healthcare Biopharma Buffer Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Merck Basic Information, Manufacturing Base and Competitors
Table 39. Merck Biopharma Buffer Major Business
Table 40. Merck Biopharma Buffer Total Revenue (USD Million) (2018-2019)
Table 41. Merck SWOT Analysis
Table 42. Merck Biopharma Buffer Product and Services
Table 43. Merck Biopharma Buffer Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. XZL BIO-TECHNOLOGY Basic Information, Manufacturing Base and Competitors
Table 45. XZL BIO-TECHNOLOGY Biopharma Buffer Major Business
Table 46. XZL BIO-TECHNOLOGY Biopharma Buffer Total Revenue (USD Million) (2018-2019)
Table 47. XZL BIO-TECHNOLOGY SWOT Analysis
Table 48. XZL BIO-TECHNOLOGY Biopharma Buffer Product and Services
Table 49. XZL BIO-TECHNOLOGY Biopharma Buffer Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. BD Basic Information, Manufacturing Base and Competitors
Table 51. BD Biopharma Buffer Major Business
Table 52. BD Biopharma Buffer Total Revenue (USD Million) (2018-2019)
Table 53. BD SWOT Analysis
Table 54. BD Biopharma Buffer Product and Services
Table 55. BD Biopharma Buffer Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Bio-Rad Basic Information, Manufacturing Base and Competitors
Table 57. Bio-Rad Biopharma Buffer Major Business
Table 58. Bio-Rad Biopharma Buffer Total Revenue (USD Million) (2018-2019)
Table 59. Bio-Rad SWOT Analysis
Table 60. Bio-Rad Biopharma Buffer Product and Services
Table 61. Bio-Rad Biopharma Buffer Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Hamilton Company Basic Information, Manufacturing Base and Competitors
Table 63. Hamilton Company Biopharma Buffer Major Business
Table 64. Hamilton Company Biopharma Buffer Total Revenue (USD Million) (2018-2019)
Table 65. Hamilton Company SWOT Analysis
Table 66. Hamilton Company Biopharma Buffer Product and Services
Table 67. Hamilton Company Biopharma Buffer Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. SRL Basic Information, Manufacturing Base and Competitors
Table 69. SRL Biopharma Buffer Major Business
Table 70. SRL Biopharma Buffer Total Revenue (USD Million) (2018-2019)
Table 71. SRL SWOT Analysis
Table 72. SRL Biopharma Buffer Product and Services
Table 73. SRL Biopharma Buffer Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Global Biopharma Buffer Sales by Manufacturer (2018-2019) (KL)
Table 75. Global Biopharma Buffer Revenue by Manufacturer (2018-2019) (USD Million)
Table 76. Global Biopharma Buffer Sales by Regions (2015-2020) (KL)
Table 77. Global Biopharma Buffer Sales Market Share by Regions (2015-2020)
Table 78. Global Biopharma Buffer Revenue by Regions (2015-2020) (USD Million)
Table 79. North America Biopharma Buffer Sales by Countries (2015-2020) (KL)
Table 80. North America Biopharma Buffer Sales Market Share by Countries (2015-2020)
Table 81. North America Biopharma Buffer Revenue by Countries (2015-2020) (USD Million)
Table 82. North America Biopharma Buffer Revenue Market Share by Countries (2015-2020)
Table 83. Europe Biopharma Buffer Sales by Countries (2015-2020) (KL)
Table 84. Europe Biopharma Buffer Sales Market Share by Countries (2015-2020)
Table 85. Europe Biopharma Buffer Revenue by Countries (2015-2020) (USD Million)
Table 86. Asia-Pacific Biopharma Buffer Sales by Regions (2015-2020) (KL)
Table 87. Asia-Pacific Biopharma Buffer Sales Market Share by Regions (2015-2020)
Table 88. Asia-Pacific Biopharma Buffer Revenue by Regions (2015-2020) (USD Million)
Table 89. South America Biopharma Buffer Sales by Countries (2015-2020) (KL)
Table 90. South America Biopharma Buffer Sales Market Share by Countries (2015-2020)
Table 91. South America Biopharma Buffer Revenue by Countries (2015-2020) (USD Million)
Table 92. South America Biopharma Buffer Revenue Market Share by Countries (2015-2020)
Table 93. Middle East & Africa Biopharma Buffer Sales by Countries (2015-2020) (KL)
Table 94. Middle East & Africa Biopharma Buffer Sales Market Share by Countries (2015-2020)
Table 95. Middle East & Africa Biopharma Buffer Revenue by Countries (2015-2020) (USD Million)
Table 96. Middle East & Africa Biopharma Buffer Revenue Market Share by Countries (2015-2020)
Table 97. Global Biopharma Buffer Sales by Type (2015-2020) (KL)
Table 98. Global Biopharma Buffer Sales Share by Type (2015-2020)
Table 99. Global Biopharma Buffer Revenue by Type (2015-2020) (USD Million)
Table 100. Global Biopharma Buffer Revenue Share by Type (2015-2020)
Table 101. Global Biopharma Buffer Sales by Application (2015-2020) (KL)
Table 102. Global Biopharma Buffer Sales Share by Application (2015-2020)
Table 103. Global Biopharma Buffer Sales Forecast by Regions (2021-2025) (KL)
Table 104. Global Biopharma Buffer Market Share Forecast by Regions (2021-2025)
Table 105. Global Biopharma Buffer Sales Forecast by Type (2021-2025) (KL)
Table 106. Global Biopharma Buffer Market Share Forecast by Type (2021-2025)
Table 107. Global Biopharma Buffer Sales Forecast by Application (2021-2025)
Table 108. Global Biopharma Buffer Market Share Forecast by Application (2021-2025)
Table 109. Direct Channel Pros & Cons
Table 110. Indirect Channel Pros & Cons
Table 111. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Biopharma Buffer Picture
Figure 2. Global Sales Market Share of Biopharma Buffer by Type in 2019
Figure 3. Phosphates Type Picture
Figure 4. Acetates Type Picture
Figure 5. TRIS Type Picture
Figure 6. Others Picture
Figure 7. Biopharma Buffer Sales Market Share by Application in 2018
Figure 8. Research Institution Picture
Figure 9. Pharmaceutical Industry Picture
Figure 10. Others Picture
Figure 11. Global Biopharma Buffer Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Biopharma Buffer Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Biopharma Buffer Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Biopharma Buffer Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Biopharma Buffer Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Biopharma Buffer Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Biopharma Buffer Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Biopharma Buffer Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Biopharma Buffer Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Biopharma Buffer Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Biopharma Buffer Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Biopharma Buffer Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Biopharma Buffer Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Biopharma Buffer Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Biopharma Buffer Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Biopharma Buffer Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Biopharma Buffer Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Biopharma Buffer Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Biopharma Buffer Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Biopharma Buffer Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Biopharma Buffer Sales Market Share by Manufacturer in 2019
Figure 32. Global Biopharma Buffer Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Biopharma Buffer Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Biopharma Buffer Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Biopharma Buffer Sales and Growth Rate (2015-2020) (KL)
Figure 37. Global Biopharma Buffer Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Biopharma Buffer Revenue Market Share by Regions (2015-2020)
Figure 39. Global Biopharma Buffer Revenue Market Share by Regions in 2018
Figure 40. North America Biopharma Buffer Sales and Growth Rate (2015-2020)
Figure 41. Europe Biopharma Buffer Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Biopharma Buffer Sales and Growth Rate (2015-2020)
Figure 43. South America Biopharma Buffer Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Biopharma Buffer Sales and Growth Rate (2015-2020)
Figure 45. North America Biopharma Buffer Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Biopharma Buffer Sales Market Share by Countries (2015-2020)
Figure 47. North America Biopharma Buffer Sales Market Share by Countries in 2018
Figure 48. North America Biopharma Buffer Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Biopharma Buffer Revenue Market Share by Countries in 2018
Figure 50. United States Biopharma Buffer Sales and Growth Rate (2015-2020) (KL)
Figure 51. Canada Biopharma Buffer Sales and Growth Rate (2015-2020) (KL)
Figure 52. Mexico Biopharma Buffer Sales and Growth Rate (2015-2020) (KL)
Figure 53. Europe Biopharma Buffer Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Biopharma Buffer Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Biopharma Buffer Revenue Market Share by Countries in 2019
Figure 56. Germany Biopharma Buffer Sales and Growth Rate (2015-2020) (KL)
Figure 57. UK Biopharma Buffer Sales and Growth Rate (2015-2020) (KL)
Figure 58. France Biopharma Buffer Sales and Growth Rate (2015-2020) (KL)
Figure 59. Russia Biopharma Buffer Sales and Growth Rate (2015-2020) (KL)
Figure 60. Italy Biopharma Buffer Sales and Growth Rate (2015-2020) (KL)
Figure 61. Asia-Pacific Biopharma Buffer Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Biopharma Buffer Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Biopharma Buffer Revenue Market Share by Regions 2019
Figure 64. China Biopharma Buffer Sales and Growth Rate (2015-2020) (KL)
Figure 65. Japan Biopharma Buffer Sales and Growth Rate (2015-2020) (KL)
Figure 66. Korea Biopharma Buffer Sales and Growth Rate (2015-2020) (KL)
Figure 67. India Biopharma Buffer Sales and Growth Rate (2015-2020) (KL)
Figure 68. Southeast Asia Biopharma Buffer Sales and Growth Rate (2015-2020) (KL)
Figure 69. South America Biopharma Buffer Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Biopharma Buffer Sales Market Share by Countries in 2019
Figure 71. South America Biopharma Buffer Revenue Market Share by Countries in 2019
Figure 72. Brazil Biopharma Buffer Sales and Growth Rate (2015-2020) (KL)
Figure 73. Argentina Biopharma Buffer Sales and Growth Rate (2015-2020) (KL)
Figure 74. Middle East and Africa Biopharma Buffer Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Biopharma Buffer Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Biopharma Buffer Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Biopharma Buffer Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Biopharma Buffer Sales and Growth Rate (2015-2020) (KL)
Figure 79. Egypt Biopharma Buffer Sales and Growth Rate (2015-2020) (KL)
Figure 80. Turkey Biopharma Buffer Sales and Growth Rate (2015-2020) (KL)
Figure 81. South Africa Biopharma Buffer Sales and Growth Rate (2015-2020) (KL)
Figure 82. Global Biopharma Buffer Sales and Growth Rate (2021-2025) (KL)
Figure 83. Global Biopharma Buffer Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Biopharma Buffer Market Forecast (2021-2025) (KL)
Figure 85. Europe Sales Biopharma Buffer Market Forecast (2021-2025) (KL)
Figure 86. Asia-Pacific Sales Biopharma Buffer Market Forecast (2021-2025) (KL)
Figure 87. South America Sales Biopharma Buffer Market Forecast (2021-2025) (KL)
Figure 88. Middle East & Africa Sales Biopharma Buffer Market Forecast (2021-2025) (KL)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
バイオファーマバッファーの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Bio Pharma Buffer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…- リモートフレームバッファプロトコルアプリケーションの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Remote Frame Buffer Protocol Application market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Remo…
- バッファータンクの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Buffer Tanks market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- バッファーエアクッションマシンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Buffer Air Cushion Machine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Buffer Air Cushion…
- バッファーエアクッションマシンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Buffer Air Cushion Machine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Buffer Air Cushion…